Urgent

Kidney disease in pregnancy

renal pregnancy · Renal / Electrolyte
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Pregnancy alters renal physiology and interacts with pre-existing CKD, glomerular disease and pre-eclampsia, affecting maternal and fetal outcomes. Multidisciplinary management focuses on BP control with pregnancy-safe agents, monitoring proteinuria/function and distinguishing pre-eclampsia from flaring kidney disease.

Red flags

  • Severe hypertension (>=160/110) or headache/visual disturbance (impending eclampsia)
  • Rapidly rising creatinine or oliguria
  • HELLP features (haemolysis, low platelets, high LFTs)
  • Thrombocytopenia with MAHA (pregnancy TMA)
  • Heavy proteinuria with declining function

Assessment

Differential diagnosis

  • Pre-eclampsia / HELLP
  • Chronic kidney disease in pregnancy
  • Lupus nephritis flare
  • Acute kidney injury of pregnancy (sepsis, haemorrhage, TMA)
  • Pregnancy-related thrombotic microangiopathy (aHUS/TTP)
  • Acute fatty liver of pregnancy

Investigations

  • BP monitoring and urine PCR/ACR (interpret against pregnancy ranges)
  • U&E/creatinine (lower normal range in pregnancy), FBC, LFTs, urate
  • Proteinuria quantification and urinalysis
  • sFlt-1/PlGF ratio where available (pre-eclampsia prediction/exclusion)
  • Lupus serology/complement and blood film (if TMA/flare suspected)
  • Renal ultrasound; fetal growth and Doppler surveillance

Management

  • Establish baseline renal function, BP and proteinuria pre-conception or early in pregnancy and risk-stratify by CKD stage
  • Switch nephrotoxic/teratogenic drugs before/at conception: stop ACE inhibitors, ARBs, SGLT2 inhibitors, mycophenolate
  • Use pregnancy-safe antihypertensives (labetalol, nifedipine, methyldopa) targeting BP ~135/85 or lower per guidance
  • Offer low-dose aspirin from 12 weeks to high-risk women to reduce pre-eclampsia risk; consider calcium supplementation if low intake
  • Monitor renal function, proteinuria and BP more frequently, especially in CKD or glomerular disease
  • Distinguish pre-eclampsia from a lupus/kidney disease flare using complement, serology, timing and sFlt-1/PlGF
  • Manage pre-eclampsia with BP control, magnesium sulfate for seizure prophylaxis in severe disease, and timely delivery
  • Continue pregnancy-compatible immunosuppression (azathioprine, hydroxychloroquine, tacrolimus) for active glomerular/lupus disease
  • Recognise and treat pregnancy-associated TMA (aHUS/TTP) urgently with specialist input
  • Coordinate obstetric, nephrology and neonatal care with a clear delivery plan
  • Plan postpartum medication reintroduction (RAAS blockade, SGLT2) and breastfeeding-compatible choices
  • Provide postpartum follow-up of renal function, BP and proteinuria

Drugs & doses

Labetalol 100-200 mg PO twice daily, titrated (first-line BP control)
Nifedipine MR 10-40 mg PO twice daily OR methyldopa 250-500 mg PO three times daily
Aspirin 150 mg PO at night from 12 weeks (pre-eclampsia prophylaxis in high risk)
Magnesium sulfate 4 g IV loading then 1 g/hour infusion (severe pre-eclampsia/eclampsia)
Azathioprine up to 2 mg/kg/day PO and hydroxychloroquine 200-400 mg PO daily (pregnancy-safe immunosuppression)
Tacrolimus continued at pregnancy-adjusted dose for transplant/glomerular disease

Disposition

Joint obstetric-nephrology (and rheumatology where relevant) care in a maternal medicine service. Admit for severe pre-eclampsia, AKI or suspected TMA. Postnatal nephrology follow-up.

Complications & pitfalls

  • Pre-eclampsia/eclampsia and HELLP
  • Accelerated loss of renal function (esp. advanced CKD)
  • Preterm birth, fetal growth restriction, stillbirth
  • Pregnancy-associated thrombotic microangiopathy
  • Postpartum hypertension and AKI

Exam pearls

  • Stop ACE inhibitors, ARBs, SGLT2 inhibitors and mycophenolate before/at conception — all teratogenic/harmful
  • Low-dose aspirin from 12 weeks reduces pre-eclampsia in high-risk women
  • Creatinine that is 'normal' may be abnormal in pregnancy — use pregnancy ranges
  • sFlt-1/PlGF helps distinguish pre-eclampsia from a kidney disease flare
  • Advanced CKD (stage 4-5) carries high risk of accelerated decline and adverse fetal outcome — counsel pre-conception

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.